Under India's National Family Planning Programme, the injectable contraceptive 'Antara' is administered as:

• A Medroxyprogesterone acetate 104 mg intramuscularly every 3 months
• B Norethisterone enanthate 200 mg intramuscularly every 2 months
• C Medroxyprogesterone acetate 104 mg subcutaneously every 3 months ✓
• D Medroxyprogesterone acetate 150 mg subcutaneously every 3 months

Explanation

Antara is depot medroxyprogesterone acetate 104 mg given by the subcutaneous route every 3 months (13 weeks). It was introduced into the public health system under the RMNCH+A strategy. The traditional DMPA preparation is 150 mg given intramuscularly, so option A fails on route and option D fails on dose. Norethisterone enanthate 200 mg every 2 months is a different progestin injectable not branded as Antara.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.